Champions Oncology, Teva Announce Partnership for Discovery, Drug Development

By: Benzinga
Champions Oncology Inc., a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the signing of a new discovery and drug development partnership with Teva Pharmaceutical Industries LTD (NYSE: TEVA ) which will utilize Champions TumorGraft™ technology platform to
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.